PT  - JOURNAL ARTICLE
AU  - Vinall, Maria
ED  - Muir, Andrew J.
TI  - DCV/ASV/BCV Improves Sustained Viral Response in Patients with Chronic HCV GT-1 Infection and Compensated Cirrhosis: UNITY-2 Results
DP  - 2014  01
TA  - MD Conference Express
PG  - 11--12
VI  - 14
IP  - 48
4099  - http://mdc.sagepub.com/content/14/48/11.short
4100  - http://mdc.sagepub.com/content/14/48/11.full
AB  - This article presents data indicating that treatment with an all-oral fixed-dose combination of daclatasvir/asunaprevir/beclabuvir with or without the addition of ribavirin is associated with high rates of sustained viral response to treatment 12 weeks after therapy in patients with chronic compensated cirrhosis and hepatitis C virus genotype 1 infection.